Litigation

• Lead counsel for the patentee in the biggest patent infringement dispute ever in Korea related to heart failure treatment patent

• Patent dispute related to diaper, which involved the largest monetary damages amount

• A number of pharmaceutical and biotech patent disputes, including a favorable decision in a pharmaceutical patent infringement preliminary injunction suit, which set a precedent in the inventiveness standard for selection invention patent

• Obtained first-ever preliminary injunction against the drug price reduction of original drug following generic launch during patent dispute

• Trade secret misappropriation dispute for major pharmaceutical companies

• Drug price reduction cancellation dispute following self-withdrawal of marketing approval

• A series of disputes related to sanitary pad TVOC

• Dispute regarding humidifier disinfectant

• Damages claim dispute for defamation of pharmaceutical company by media company

• Trade secret misappropriation suit for a global pharmaceutical company

• A number of pharmaceutical patent disputes with regard to patent approval linkage system for a global pharmaceutical company

• Patent infringement dispute between Korea’s largest film manufacturer and Japan’s largest film manufacturer

• Dmages claim dispute against a pharmaceutical company on behalf of National Health Insurance Service following the marketing approval cancellation

• Patent infringement dispute related to computer program for the biggest software company in the world

• Trademark dispute related to the name of large business group

• Damages claim dispute for trade secret misappropriation against a competitor on behalf of an ai conditioner manufacturer

• Administrative disposition cancellation action for a health functional food company

• Patent infringement dispute between a Korean electronic device manufacturer and Japanese electronic device manufacturer

• A number of suits for cancellation of environmental waste charge imposition

• Patent invalidation dispute regarding optical communication cable company

• Dispute regarding asebestos damage

Counseling

• Advise global pharmaceutical companies regarding biosimilar patent disputes

• Advise domestic and global pharmaceutical companies regarding licensing out and related disputes

• Advise pharmaceutical companies when entering overseas markets with regard to license, approval, patents, trademarks, etc.

• Advise on the safety of home environment products

• Advise client on damages compensation regarding humidifier disinfectant and National Assembly Hearing

• Advise pharmaceutical companiaes on Pharmaceutical Affairs Act, reibursement drug price, Fair Trade Act, Trademark Act, Patent Act, as well as various contract documents including drug supply agreement

• Advise food companies on Food Sanitation Act, Livestock Processing Act, and Fair Trade Act

• Advise bio startups on Pharmaceutical Affairs Act, Medical Service Act, Patent Act, and various contract documents including technology transfer

• Advise beverage and milk companies on Food Sanitation Act and bio patents

• Advise medical device manufacturers on Medical Device Act, Fair Labeling and Advertising Act, etc. in response to criminal charge or MFDS action

• Advise semiconductor manufacturers on Patent Act and other relevant issues

• Advise clients on Environmental Damage Compensation Act

• Advise household product companies on patent infringement damages calculation

• Advise clients on plant variety importation and improvement contract

• Advise clients on defamation issue due to media coverage related to food or drug products

• Advise hospitals related to recovery of reimbursement claims by Health Insurance Review and Assessment Service

• Advise health functional food companies on Health Functional Food Act, etc.

• Advise beverage companies on Fair Labeling and Advertising Act, Food Sanitation Act, Pharmaceutical Affairs Act, Health Functional Food Act, etc.

• Advise cosmetics companies on Comsetic Product Act

• Patent Term Extension of Pharmaceutical Patent and the Role of the Regulatory Agency (FDC regulatory Science Academy) (2024)
• KDRA Lecturer on Patent Approval Linkage System (2023~2024)
• MFDS Lecturer on Patent Approval Linkage System (2020~2021)
• 2020 Life Sciences South Korea, Lexology Getting The Deal Through
• Challenges for Biosimilars In Korean Market (Global Biosimilar Summit (Munich), Speaker, 2019)
• Successful Challenges to Korea Health Insurance Regulator's 13-years Old System of Automatic Reduction of Original Drug Price (Legal 500, 2019)
• Joint Conference (LEEKO/ Foley and Lardner, Moderator, Bio Korea, 2019)
• Joint Conference (LEEKO/ McDermott Will & Emery LLP) Pharma-Patent Protection in Korea and US (Speaker, 2018)
• Evidence in Korean Patent Infringement (APAA Auckland Workshop, Speaker, 2017)
• Joint Conference (LEEKO/ Foley and Lardner) Patent Strategy in Pharma and Bio Industry (Speaker, 2017)
• Lecturer of Improper Solicitation and Graft Act (MFDS, 2017)
• Lecturer of Pharmaceutical Affairs Act (Korea Human Resource Development Institute for Health & Welfare, 2017)
• Lecturer of KPMA / MFDS sponsored Pharmaceutical Patent-Regulation Education Program (2016)
• '3D-Printing and IP' (APAA Penang Emerging IP Committee, Speaker, 2014)
• 'Taking Control of your IP Dispute using ADR' (APAA Penang ADR Workshop, Speaker, 2014)
• 'Practical Application & Problems of Patent Approval Linkage System ' (KFDC Fall Session, Speaker, 2014)
• Space Law Committee Session 'Telemedicine by satellite : Improving healthcare and creating legal and ethical issues,'(IBA Tokyo Conference, Speaker, 2014)
• 'South Korea's Patent-Approval Linkage System,' (Intellectual Asset Management Magazine, 2014)
• 'Newly Established Patent Approval Linkage System' (Bio Korea special Session/ KFDC Seminar 2014)
• 'Patentability of Chemical and Pharmaceutical Inventions-Enantiomer Invention, Crystalline Invention, and Selection Invention ,' (Law & Technology, 2013)
• 'Chemical/Pharmaceutical Patent's Patentability,' (Korea-US IP Judicial Conference, Speaker, 2013)
• Life Science Session 'Stem Cell Therapy Regulation in Korea,' (IBA Boston Conference , Speaker, 2013)
• 'Patentability of Pharmaceutical Inventions,' (Judicial Training Seminar, 2013)
• 'Life Sciences South Korea Part,' (The Law and Leading Lawyers Worldwide, 2011)
• 'Understanding the Patent System,' (Seoul National University, College of Pharmacy, 2010)